z-logo
open-access-imgOpen Access
Sticky Issues: What APs Need to Know About Anticoagulants and Patients With Cancer
Author(s) -
Val R. Adams
Publication year - 2021
Publication title -
journal of the advanced practitioner in oncology
Language(s) - English
Resource type - Journals
eISSN - 2150-0886
pISSN - 2150-0878
DOI - 10.6004/jadpro.2021.12.3.8
Subject(s) - medicine , venous thromboembolism , intensive care medicine , cancer , thrombosis
During the JADPRO Live Virtual 2020 conference, Val R. Adams, PharmD, FCCP, FHOPA, BCOP, discussed how to determine which patients with cancer should be treated with direct oral anticoagulants (DOACs), the similarities and differences between the DOACs, and recent data on the prevention and treatment of cancer-associated venous thromboembolism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here